YANG Mian-ling, CHENG Yu-sen, SONG Le-tian, YE Bing, GAO Sheng-hua, LIU Xin-yong, ZHAN Peng. Research progress of SARS-CoV-2 main protease inhibitorsJ. Acta Pharmaceutica Sinica, 2023, 58(9): 2581-2600. DOI: 10.16438/j.0513-4870.2022-1364
Citation: YANG Mian-ling, CHENG Yu-sen, SONG Le-tian, YE Bing, GAO Sheng-hua, LIU Xin-yong, ZHAN Peng. Research progress of SARS-CoV-2 main protease inhibitorsJ. Acta Pharmaceutica Sinica, 2023, 58(9): 2581-2600. DOI: 10.16438/j.0513-4870.2022-1364

Research progress of SARS-CoV-2 main protease inhibitors

  • As a common protease with high similarity among coronavirus species, the main protease (Mpro) of SARS-CoV-2 is responsible for the catalytic hydrolysis of viral precursor proteins into functional proteins, which is essential for coronavirus replication and is one of the ideal targets for the development of broad-spectrum antiviral drugs. This paper reviews the main protease inhibitors of SARS-CoV-2, including their molecular structures, potencies and drug-like profiles, binding modes and structure-activity relationships, etc.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return